United Therapeutics (UTHR): are the analysts right?

United Therapeutics · Health Care · ref. ETF XLV · 84 calls · price $546.99
What the company does: United Therapeutics développe et commercialise des produits pour traiter les maladies chroniques et graves.
📈 1-year price
$563.7+91.5% over range
Jul 8, 25low $274.7 · high $596.76Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
78% recommend buying · 9 analysts

🎯 Analyst price target on UTHR

High target · 1 analyst$738+34.9%
Median target · 9 analysts$660+20.7%
Low target · 1 analyst$519-5.1%
Current price$546.99

🗳️ The analyst consensus

Analyst breakdown · 9 (6 months)
Strong Buy0%
Buy78%
Hold22%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on UTHR

Most reliable analysts on UTHR (% profitable · 365j · ≥2 calls)
JP Morgan 100% +96.7% 2
Ladenburg Thalmann 100% +29.1% 8
Wedbush 70% +26.1% 10
Argus Research 60% +1.5% 5
HC Wainwright & Co. 50% +19.7% 12

📊 What $1,000 invested in United Therapeutics would be worth

In short — $1,000 invested in United Therapeutics 10 years ago would be worth $3,460 today, i.e. +13%/yr on average. Best year: 2020 (+72%), worst: 2018 (-26%). Price performance, excluding dividends.

If I'd invested $1,000 in United Therapeutics

InvestmentWorth todayGain
1 years ago$1,536+54%
3 years ago$1,948+95%
5 years ago$3,570+257%
10 years ago$3,460+246%
since inception (1999)$59,176+5818%

Return by year (United Therapeutics)

YearReturn$1,000 invested at year start
2026 (YTD)+11%$1,112 (+11%)
2025+38%$1,536 (+54%)
2024+60%$2,464 (+146%)
2023-21%$1,948 (+95%)
2022+29%$2,508 (+151%)
2021+42%$3,570 (+257%)
2020+72%$6,152 (+515%)
2019-19%$4,975 (+398%)
2018-26%$3,662 (+266%)
2017+3%$3,778 (+278%)
2016-8%$3,460 (+246%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on UTHR

RBC Capital
May 7, 26
▲ Outperform · 🎯$701
Price at call : $564.94 — upside +24%
Today : $546.99 — upside +28%
🎯 on UTHR : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : May 7, 27
Wells Fargo
May 7, 26
▲ Overweight · 🎯$738
Price at call : $564.94 — upside +31%
Today : $546.99 — upside +35%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : May 7, 27
■ Equal-Weight neutral · not a buy · 🎯$519
Price at call : $577.63 — gap to target -10%
Today : $546.99 — gap to target -5%
🎯 on UTHR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Apr 10, 27
▲ Buy · 🎯$660
Price at call : $570.27 — upside +16%
Today : $546.99 — upside +21%
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Mar 31, 27
Wells Fargo
Mar 31, 26
■ Equal-Weight neutral · not a buy · 🎯$575
Price at call : $570.27 — gap to target +1%
Today : $546.99 — gap to target +5%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Mar 31, 27
■ Neutral neutral · not a buy · 🎯$626
Price at call : $592.98 — gap to target +6%
Today : $546.99 — gap to target +14%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Mar 31, 27
TD Cowen
Mar 30, 26
▲ Buy · 🎯$660
Price at call : $592.98 — upside +11%
Today : $546.99 — upside +21%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Mar 30, 27
Wells Fargo
Mar 23, 26
■ Equal-Weight neutral · not a buy · 🎯$486
Price at call : $521.22 — gap to target -7%
Today : $546.99 — gap to target -11%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Mar 23, 27
▲ Overweight · 🎯$625
Price at call : $536.12 — upside +17%
Today : $546.99 — upside +14%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 58.8% · +20.2% (97 calls)
in progress (365j)
matures : Mar 12, 27
UBS
Mar 5, 26
▲ Buy · 🎯$705
Price at call : $478.16 — upside +47%
Today : $546.99 — upside +29%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Mar 5, 27
▲ Buy · 🎯$600
Price at call : $503.9 — upside +19%
Today : $546.99 — upside +10%
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 26, 27
TD Cowen
Feb 26, 26
▲ Buy · 🎯$575
Price at call : $503.9 — upside +14%
Today : $546.99 — upside +5%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Feb 26, 27
Oppenheimer
Feb 26, 26
▲ Outperform · 🎯$600
Price at call : $503.9 — upside +19%
Today : $546.99 — upside +10%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 52.9% · +4.5% (68 calls)
in progress (365j)
matures : Feb 26, 27
RBC Capital
Feb 26, 26
▲ Outperform · 🎯$643
Price at call : $503.9 — upside +28%
Today : $546.99 — upside +18%
🎯 on UTHR : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 26, 27
Wells Fargo
Feb 26, 26
■ Equal-Weight neutral · not a buy · 🎯$466
Price at call : $503.9 — gap to target -8%
Today : $546.99 — gap to target -15%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 26, 27
UBS
Jan 6, 26
▲ Buy · 🎯$645
Price at call : $503.69 — upside +28%
Today : $546.99 — upside +18%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jan 6, 27
UBS
Nov 6, 25
▲ Buy · 🎯$600
Price at call : $448.91 — upside +34%
Today : $546.99 — upside +10%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Nov 6, 26
▲ Buy · 🎯$525
Price at call : $445.43 — upside +18%
Today : $546.99 — upside -4%
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Oct 30, 26
RBC Capital
Oct 30, 25
▲ Outperform · 🎯$587
Price at call : $445.43 — upside +32%
Today : $546.99 — upside +7%
🎯 on UTHR : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$423
Price at call : $445.43 — gap to target -5%
Today : $546.99 — gap to target -23%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Oct 30, 26
■ Equal-Weight neutral · not a buy · 🎯$435
Price at call : $440.06 — gap to target -1%
Today : $546.99 — gap to target -20%
🎯 on UTHR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Oct 10, 26
UBS
Sep 29, 25
▲ Buy · 🎯$580
Price at call : $419.21 — upside +38%
Today : $546.99 — upside +6%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Sep 29, 26
RBC Capital
Sep 26, 25
▲ Outperform · 🎯$569
Price at call : $432.66 — upside +32%
Today : $546.99 — upside +4%
🎯 on UTHR : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Sep 26, 26
▲ Overweight · 🎯$525
Price at call : $396.5 — upside +32%
Today : $546.99 — upside -4%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 58.8% · +20.2% (97 calls)
in progress (365j)
matures : Sep 10, 26
Oppenheimer
Sep 5, 25
▲ Outperform · 🎯$575
Price at call : $394.62 — upside +46%
Today : $546.99 — upside +5%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 52.9% · +4.5% (68 calls)
in progress (365j)
matures : Sep 5, 26
▲ Buy · 🎯$500
Price at call : $400.52 — upside +25%
Today : $546.99 — upside -9%
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 5, 26
UBS
Sep 4, 25
▲ Buy · 🎯$560
Price at call : $380.47 — upside +47%
Today : $546.99 — upside +2%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Sep 4, 26
Wells Fargo
Sep 3, 25
■ Equal-Weight neutral · not a buy · 🎯$414
Price at call : $391.45 — gap to target +6%
Today : $546.99 — gap to target -24%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Sep 3, 26
Jefferies
Sep 2, 25
▲ Buy · 🎯$564
Price at call : $391.45 — upside +44%
Today : $546.99 — upside +3%
🎯 on UTHR : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Sep 2, 26
■ Neutral neutral · not a buy · 🎯$463
Price at call : $391.45 — gap to target +18%
Today : $546.99 — gap to target -15%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Sep 2, 26
UBS
Aug 13, 25
▲ Buy · 🎯$415
Price at call : $309.72 — upside +34%
Today : $546.99 — upside -24%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Aug 13, 26
Wells Fargo
Jul 31, 25
■ Equal-Weight neutral · not a buy · 🎯$295
Price at call : $294.28 — gap to target +0%
Today : $546.99 — gap to target -46%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Jul 31, 26
▲ Buy · 🎯$400
Price at call : $274.7 — upside +46%
Today : $546.99 — upside -27%
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Jul 31, 26
■ Equal-Weight neutral · not a buy · 🎯$328
Price at call : $295.52 — gap to target +11%
Today : $546.99 — gap to target -40%
🎯 on UTHR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jul 10, 26
JP Morgan
Jul 8, 25
▲ Overweight · 🎯$330
Price at call : $300.56 — upside +10%
Today : $546.99 — upside -40%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jul 8, 26
UBS
Jun 30, 25
▲ Buy · 🎯$385
Price at call : $290.91 — upside +32%
Today : $546.99 — upside -30%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jun 30, 26
■ Neutral neutral · not a buy · 🎯$315
Price at call : $286.14 — gap to target +10%
Today : $546.99 — gap to target -42%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Jun 11, 26
▲ Overweight · 🎯$405
Price at call : $324.2 — upside +25%
Today : $546.99 — upside -26%
Expected +25% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 58.8% · +20.2% (97 calls)
+69.5%
stock +69% · XLV +11%
▲ Buy · 🎯$425
Price at call : $298.7 — upside +42%
Today : $546.99 — upside -22%
Expected +42% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+91.6%
stock +92% · XLV +5%
JP Morgan
May 1, 25
▲ Overweight · 🎯$350
Price at call : $294.6 — upside +19%
Today : $546.99 — upside -36%
Expected +19% · Actual +97% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
+97.3%
stock +97% · XLV +4%
■ Equal-Weight neutral · not a buy · 🎯$348
Price at call : $294.6 — gap to target +18%
Today : $546.99 — gap to target -36%
🎯 on UTHR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : May 1, 26
■ Neutral neutral · not a buy · 🎯$321
Price at call : $293.85 — gap to target +9%
Today : $546.99 — gap to target -41%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : May 1, 26
Wells Fargo
Apr 25, 25
■ Equal-Weight neutral · not a buy · 🎯$314
Price at call : $291.38 — gap to target +8%
Today : $546.99 — gap to target -43%
🎯 on UTHR : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Apr 25, 26
JP Morgan
Apr 21, 25
▲ Overweight · 🎯$355
Price at call : $292.82 — upside +21%
Today : $546.99 — upside -35%
Expected +21% · Actual +96% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
+96.1%
stock +96% · XLV +8%
■ Neutral neutral · not a buy · 🎯$314
Price at call : $284.25 — gap to target +10%
Today : $546.99 — gap to target -43%
🎯 on UTHR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Apr 21, 26
▲ Buy · 🎯$425
Price at call : $323.62 — upside +31%
Today : $546.99 — upside -22%
Expected +31% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+55.7%
stock +56% · XLV +9%
UBS
Jan 8, 25
▲ Buy · 🎯$475
Price at call : $364.97 — upside +30%
Today : $546.99 — upside -13%
Expected +30% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
+32.4%
stock +32% · XLV +13%
■ Neutral neutral · not a buy · 🎯$302
Price at call : $376.8 — gap to target -20%
Today : $546.99 — gap to target -45%
🎯 on UTHR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Nov 1, 25
▲ Buy · 🎯$344
Price at call : $374.02 — upside -8%
Today : $546.99 — upside -37%
Expected -8% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 75% · +16.2% (8 calls)
+17.3%
stock +17% · XLV -2%
Oppenheimer
Oct 31, 24
▲ Outperform · 🎯$600
Price at call : $374.02 — upside +60%
Today : $546.99 — upside +10%
Expected +60% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 52.9% · +4.5% (68 calls)
+17.3%
stock +17% · XLV -2%
▲ Buy · 🎯$400
Price at call : $374.02 — upside +7%
Today : $546.99 — upside -27%
Expected +7% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+17.3%
stock +17% · XLV -2%
▲ Buy · 🎯$425
Price at call : $374.02 — upside +14%
Today : $546.99 — upside -22%
Expected +14% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+17.3%
stock +17% · XLV -2%
▲ Buy · 🎯$400
Price at call : $327.79 — upside +22%
Today : $546.99 — upside -27%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-10.2%
stock -10% · XLV -13%
▲ Buy · 🎯$400
Price at call : $336.37 — upside +19%
Today : $546.99 — upside -27%
Expected +19% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-9.5%
stock -9% · XLV -8%
▲ Buy · 🎯$300
Price at call : $258.13 — upside +16%
Today : $546.99 — upside -45%
Expected +16% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+14.1%
stock +14% · XLV -1%
Wedbush
Feb 22, 24
▲ Outperform · 🎯$308
Price at call : $217.6 — upside +42%
Today : $546.99 — upside -44%
Expected +42% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
+66.0%
stock +66% · XLV -1%
▲ Buy · 🎯$300
Price at call : $217.6 — upside +38%
Today : $546.99 — upside -45%
Expected +38% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 50% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+66.0%
stock +66% · XLV -1%
▲ Outperform · 🎯$330
Price at call : $212.76 — upside +55%
Today : $546.99 — upside -40%
Expected +55% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)
+66.1%
stock +66% · XLV +3%
Wedbush
Nov 2, 23
▲ Outperform · 🎯$308
Price at call : $228.18 — upside +35%
Today : $546.99 — upside -44%
Expected +35% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 40% · +1.1% (30 calls)
+63.9%
stock +64% · XLV +17%
▲ Buy · 🎯$268
Price at call : $231.87 — upside +16%
Today : $546.99 — upside -51%
Expected +16% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 75% · +16.2% (8 calls)
+41.3%
stock +41% · XLV +14%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)